Skip to main content
Image of a medical professional holding a vaccine vile

A version of this article previously appeared on the American Public Health Association's Public Health Newswire. For the original article, please visit APHA Public Health Newswire.

In the aftermath of the global pandemic, vaccine-preventable disease (VPD) coverage rates have fallen, presenting a complex challenge that necessitates a coordinated approach from both state and federal governments. The key lies not just in expanding funding but in the strategic allocation and effective use of these resources.

Vaccine Coverage in the Post-Pandemic Era

As we resume regular school activities, the risk of VPD outbreaks due to lagging vaccine coverage becomes a pressing concern. Mitigating this risk depends on effective collaboration between the state and federal entities tasked with ensuring comprehensive vaccine access.

The Role of Federal and State Agencies

The U.S. vaccine ecosystem relies heavily on symbiotic relationships between government agencies like the FDA, CDC, and state health authorities. These partnerships are crucial for maintaining a safe and reliable vaccine supply and for implementing programs that effectively reach all demographics, especially vulnerable communities within our population.

Understanding the Socio-Economic Dynamics

A critical aspect that often gets overlooked is the socio-economic factors influencing vaccine coverage. Families facing instability in economics, housing, and employment are at a greater risk of low health insurance and vaccine coverage resulting from reduced access to medical care. This insight forms the basis of CDC's principle that investing in vaccines is the most cost-effective disease prevention strategy.

Strategic Intervention and Maximus' Role

Recognizing the challenges in the current vaccine distribution model, especially in reaching children without adequate insurance or access to healthcare, Maximus recognizes the need for a strategic intervention. Leveraging our expertise in data analytics and program management, we aim to efficiently and effectively support state health agencies in identifying and addressing gaps in vaccine coverage.

Enhancing Current Programs and Proposing New Initiatives

Programs like Vaccines for Children and Section 317 play a pivotal role in vaccine distribution; however, there is a pressing need to extend these efforts to include adult immunization, particularly among uninsured and under-insured groups. Maximus supports the proposed Vaccines for Adults Program, emphasizing its potential to transform the landscape of adult immunization in the U.S. by increasing access to vaccines for adults at high risk for severe outcomes from VPD.

A Call to Unified Action

At this critical juncture of public health and government program strategy, the concerted efforts of government agencies, backed by strategic partners like Maximus, can lead to a significant improvement in national vaccination rates. The time is ripe for such unified action, and Maximus stands ready to lend its expertise and resources to this vital mission to save lives.

For more insights and detailed information on how Maximus is innovating in public health infrastructure and addressing modern healthcare challenges, visit the Maximus Center for Health Innovation (CHI). Learn about our comprehensive programs, services, and technology solutions tailored to meet today's evolving population health needs.